Trademark Overview
On Thursday, April 17, 2025, a trademark application was filed for SENSORIUM with the United States Patent and Trademark Office. The USPTO has given the SENSORIUM trademark a serial number of 99141812. The federal status of this trademark filing is NEW APPLICATION - RECORD INITIALIZED NOT ASSIGNED TO EXAMINER as of Thursday, April 17, 2025. This trademark is owned by Sensorium Therapeutics, Inc.. The SENSORIUM trademark is filed in the Pharmaceutical Products, Computer & Software Services & Scientific Services, and Medical & Beauty Services & Agricultural Services categories with the following description:
Pharmaceutical preparations for human use for the treatment of diseases of the central nervous system, psychiatric, neurological, and neurodegenerative disorders; pharmaceutical preparations for medical and therapeutic purposes for the treatment of diseases of the central nervous system, psychiatric, neurological, and neurodegenerative disorders
Providing information relating to the diagnostic, prophylactic, and therapeutic properties of pharmaceutical preparations and biologic preparations for the prevention and treatment of human and veterinary neurological, neurodegenerative and other central nervous system diseases, disorders, and conditions
Providing scientific and technological information, namely, results from medical research, scientific research and analysis in the fields of pharmaceuticals and biomedicine; Providing scientific information, namely, results from pharmaceutical, biomedical and biological therapeutic research; research in the fields of pharmaceutical and biologic therapeutic preparations, clinical trials and post-market trials; pharmaceutical research and development; providing scientific research information in the fields of pharmaceuticals, biomedicine, clinical trials and post-market trials; providing a website featuring research and development information in the therapeutics, pharmaceutical and biotechnology fields for treatment of diseases of the central nervous system, psychiatric, neurological, and neurodegenerative disorders; research and development of therapeutics